Clinical Trial Update: Effect of Erythropoietin on Neurodevelopmental Outcomes in Very Preterm Infants With Intraventricular Hemorrhage [Phase 2]

View source ↗

Summary

Phase 2 trial updating the effect of erythropoietin on neurodevelopmental outcomes in very preterm infants with intraventricular hemorrhage (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraventricular Hemorrhage in Preterm Infants
• Premature Infants

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Zhengzhou University | Conditions: Premature Infants | Phase 2 | Status: COMPLETED